Product Information
SEROQUEL 200 MG TABLET is a brand product labeled by AstraZeneca Pharmaceuticals LP, priced at $11.9902 per EA under NDC 00310027210. Its NADAC has been published 366 times since Nov 28, 2013.
FDA first approved this application on Sep 26, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the quetiapine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
AstraZeneca Pharmaceuticals LPNDC
00310027210
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA020639FDA Approved
9/26/1997
TE Code
AB
On Market Since
10/1/1997
Pharmacological Classes
Price Statistics
The NADAC for SEROQUEL 200 MG TABLET has been published 366 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.9902 per EA |
|---|---|
| All-time high | $12.5157 (Jun 15, 2016) |
| All-time low | $11.6320 (Jun 17, 2015) |
| 52-week high | $12.0075 |
| 52-week low | $11.9773 |
| Median price | $12.0669 |
| Average price | $12.0516 |
| Largest weekly change | +4.6% (Sep 23, 2015) |
| Weeks tracked | 366 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SEROQUEL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SEROQUEL 200 MG TABLET, manufactured by AstraZeneca Pharmaceuticals LP, is $11.9902 per EA (NDC 00310027210), effective Aug 19, 2026.
How has the price of SEROQUEL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for SEROQUEL 200 MG TABLET has held within roughly two percent of its current level. It has been tracked across 366 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SEROQUEL 200 MG TABLET?
Since Nov 28, 2013, the NADAC for SEROQUEL 200 MG TABLET has ranged from a low of $11.6320 (Jun 17, 2015) to a high of $12.5157 (Jun 15, 2016), with a median of $12.0669 per EA.
Are there cheaper alternatives to SEROQUEL 200 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 200 MG TAB, is $0.0857 per EA — about 99% below SEROQUEL 200 MG TABLET.
Who manufactures SEROQUEL 200 MG TABLET?
SEROQUEL 200 MG TABLET (NDC 00310027210) is labeled by AstraZeneca Pharmaceuticals LP, and CMS classifies it as a brand product.